Brentuximab vedotin with etoposide, cyclophosphamide, doxorubicin, dacarbazine and dexamethasone for untreated advanced classical Hodgkin lymphoma ID6437 Consultation on suggested remit, draft scope ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results